title: [The association of stroke with high plasma low-density lipoprotein cholesterol level and metabolic syndrome in Chinese adults].
abstract: OBJECTIVE
  To investigate the impact of high plasma LDL-C level with or without metabolic syndrome (MS) on the incidence of stroke in Chinese adults.
  
  
  METHODS
  Totally 42 626 subjects (25-75 years old) from Chinese National Health and Nutrition Survey in 2002 were stratified four groups based on plasma LDL-C level:<2.00 mmol/L group, 2.00-2.50 mmol/L group, 2.51-3.31 mmol/L group, and >or=3.32 mmol/L group. The prevalence of MS (with 2005 International Diabetes Federation criteria) and stroke and the risk factors of stroke were compared among the four groups.
  
  
  RESULTS
  (1) The prevalence of MS and stroke increased with rising of LDL-C level. The prevalence of MS in LDL-C>or=3.32 mmol/L group increased 2.5 times (7.9% vs 20.1%) as compared with that in LDL-C<2.00 mmol/L group and the prevalence of stroke increased 4.2 times (0.5% vs 2.1%), all P<0.01. (2) In subjects with similar LDL-C level, the prevalence of stroke was significantly higher in a subgroup with MS than that without (P<0.01). (3) After adjustment for age, sex and smoking, logistic regression analysis showed that both LDL-C level and MS were positively associated with the development of stroke; the odds ratio (OR) was 2.35 and 3.15 (P<0.0001), respectively. (4) Compared with the subgroup of LDL-C<2.00 mmol/L without MS, OR for stroke in the subgroups of LDL-C 2.00-2.50 mmol/L, 2.51-3.31 mmol/L, and >or=3.32 mmol/L without MS was 1.03, 1.89, and 2.08, whereas the OR for stroke in the subgroups with MS and similar level of LDL-C was 4.38, 5.23 and 6.15; this indicated that the risk of stroke in subjects with MS increased by 3-4 times compared with subjects without (P<0.0001).
  
  
  CONCLUSIONS
  Both high LDL-C level and MS are independent risk factors of stroke, but the risk of stroke will be further increased in the presence of high LDL-C level plus MS. It is suggested that combined intervention therapy of LDL-C and MS will play an important role in the prevention of stroke.
authors.affiliation: Center of Endocrinology and Metabolism, China-Japan Friendship Hospital, Beijing 100029, China.
authors.forename: Xiao-yan
authors.initials: XY
authors.lastname: Xing
authors.forename: Guang-wei
authors.initials: GW
authors.lastname: Li
authors.forename: Chong-hua
authors.initials: CH
authors.lastname: Yao
authors.forename: Ke-qin
authors.initials: KQ
authors.lastname: Rao
authors.forename: Ling-zhi
authors.initials: LZ
authors.lastname: Kong
mesh_terms: D000328:Adult; D000368:Aged; D044466:Asian People; D008078:Cholesterol, LDL / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood / Q000453:epidemiology*; D008875:Middle Aged; D015995:Prevalence; D012307:Risk Factors; D020521:Stroke / Q000097:blood / Q000453:epidemiology*
chemical_list: D008078:Cholesterol, LDL